BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20601938)

  • 1. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics.
    Yoshida A; Ushiku T; Motoi T; Shibata T; Beppu Y; Fukayama M; Tsuda H
    Mod Pathol; 2010 Sep; 23(9):1279-88. PubMed ID: 20601938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
    Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
    Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.
    Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
    J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
    Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
    Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
    Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
    Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.
    Limbach AL; Lingen MW; McElherne J; Mashek H; Fitzpatrick C; Hyjek E; Mostofi R; Cipriani NA
    Head Neck Pathol; 2020 Dec; 14(4):889-898. PubMed ID: 32026294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
    Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
    Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 and CDK4 expression in periosteal osteosarcoma.
    Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
    Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions.
    Kaur H; Kala S; Sood A; Mridha AR; Kakkar A; Yadav R; Mishra S; Mishra D
    Head Neck Pathol; 2022 Sep; 16(3):728-737. PubMed ID: 35220546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases.
    Hayashi K; Tsuchiya H; Yamamoto N; Shirai T; Nishida H; Takeuchi A; Kimura H; Miwa S; Inatani H; Okamoto H; Yamada S; Ikeda H; Sawada-Kitamura S; Nojima T; Ooi A; Otsuka T
    Int J Clin Oncol; 2014 Aug; 19(4):731-8. PubMed ID: 23881556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
    Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
    Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical and FISH analysis of MDM2 and CDK4 in a dedifferentiated extraskeletal osteosarcoma arising in the vastus lateralis muscle: differential diagnosis and diagnostic algorithm.
    von Baer A; Ehrhardt A; Baumhoer D; Mayer-Steinacker R; Schultheiss M; Abdul-Nou T; Mentzel T; Fend F; Möller P; Jundt G; Barth TF
    Pathol Res Pract; 2014 Oct; 210(10):698-703. PubMed ID: 24974983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
    Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
    Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.
    Lopes MA; Nikitakis NG; Ord RA; Sauk J
    Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parosteal osteosarcoma.
    Hang JF; Chen PC
    Arch Pathol Lab Med; 2014 May; 138(5):694-9. PubMed ID: 24786129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
    Chow LT
    Virchows Arch; 2016 Jun; 468(6):741-55. PubMed ID: 27003154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of MDM2 gene amplification by fluorescence in situ hybridization and its diagnostic value in low-grade osteosarcoma].
    Li L; Zhang M; Dong RF; Su YB; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):237-242. PubMed ID: 38433050
    [No Abstract]   [Full Text] [Related]  

  • 20. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
    Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
    Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.